The Clinical Impact of Hemoglobin, Albumin, Lymphocyte, Platelet (HALP) in Gastric Cancer Patients Who Receive Curative Treatment.
Toru AoyamaYukio MaezawaItaru HashimotoRyuki EsashiSosuke YamamotoMamoru UchiyamaKoji NumataKeisuke KazamaAyako TamagawaAya SaitoNorio YukawaPublished in: In vivo (Athens, Greece) (2024)
The HALP score affects both short- and long-term oncological outcomes. Thus, the HALP score may be a promising prognostic factor for the treatment and management of GC.